PROMISE
BioPrinted hydROgel MicrofluIdicS to mimic patient-specific tumor mEtastatic microenvironment
Colorectal cancer patients have good chances of surviving primary tumors, but when metastasis comes, treatment options are limited, and patient’s response is not easy to predict. Results of PROMISE project aim to provide clinicians with better tools to understand and monitor therapeutic approaches of metastatic colorectal cancer patients. We believe that advanced bioengineering solutions combining new technologies such as bioprinting, biomaterials and microfluidics can provide researchers and doctors with a set of powerful devices that will definitely impact metastasis understanding and, ultimately, life expectancy of metastatic cancer patients. 3
Total Eligible Budget
981,675.00 €
INL Eligible Budget
296,089.17 €
INL Funding
296,089.17 €
Start Date
01-12-2020
End Date
31-05-2025
Grant Agreement Id
HR20-00637
Funding Framework
La Caixa Foundation – Health Research Programme
INL Role
Partner
Approval Date